PomalidomideFirst report of drug-induced liver injury: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2014年 / 1510卷 / 1期

关键词：

D O I：

10.1007/s40278-014-2053-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：35 / 35

相关论文

共 50 条

[1] LevocetirizineFirst report of drug-induced liver injury: case report
Reactions Weekly, 2017, 1642 (1) : 180 - 180
[2] CanagliflozinFirst report of drug-induced liver injury: case report
Reactions Weekly, 2015, 1539 (1) : 75 - 75
[3] TerbinafineCholestatic drug-induced liver injury: case report
Reactions Weekly, 2023, 1960 (1) : 402 - 402
[4] DoxazosinAsthenia and drug-induced liver injury: case report
Reactions Weekly, 2021, 1873 (1) : 106 - 106
[5] AlemtuzumabHepatitis and drug-induced liver injury: case report
Reactions Weekly, 2019, 1738 (1) : 15 - 15
[6] ThiamazoleCholestatic drug-induced liver injury: case report
Reactions Weekly, 2025, 2051 (1) : 302 - 302
[7] DaptomycinRhabdomyolysis and drug-induced liver injury: case report
Reactions Weekly, 2016, 1605 (1) : 68 - 68
[8] ClotrimazoleAcute drug-induced liver injury: case report
Reactions Weekly, 2022, 1896 (1) : 136 - 136
[9] DiclofenacIdiosyncratic drug-induced liver injury: case report
Reactions Weekly, 2024, 2027 (1) : 170 - 170
[10] MifepristoneCholestatic drug-induced liver injury: case report
Reactions Weekly, 2019, 1759 (1) : 179 - 179

← 1 2 3 4 5 →